XML 54 R40.htm IDEA: XBRL DOCUMENT v3.25.0.1
COMMITMENTS AND CONTINGENCIES (Details Narrative) - USD ($)
12 Months Ended
Jul. 23, 2022
Sep. 27, 2021
Sep. 27, 2021
Sep. 23, 2021
Dec. 31, 2024
Dec. 31, 2023
Loss Contingencies [Line Items]            
Proceeds from sale of stock   $ 116,150,000   $ 116,150,000    
Percentage of aggregate sales price of securities sold 5.00%          
Deferred underwriting commissions       $ 4,025,000 $ 4,025,000 $ 4,025,000
Aggregrate 3% [Member]            
Loss Contingencies [Line Items]            
Aggregrate value $ 100,000,000          
Aggregrate 2% [Member] | Minimum [Member]            
Loss Contingencies [Line Items]            
Aggregrate value 100,000,000          
Aggregrate 2% [Member] | Maximum [Member]            
Loss Contingencies [Line Items]            
Aggregrate value 200,000,000          
Aggregrate 1 % [Member]            
Loss Contingencies [Line Items]            
Aggregrate value 200,000,000          
Chardan [Member]            
Loss Contingencies [Line Items]            
Management fee $ 800,000          
Percentage of aggregate value of initial public combination 1.00%          
Chardan [Member] | Maximum [Member]            
Loss Contingencies [Line Items]            
Aggregrate reimbursable out of pocket expenses         $ 150,000  
Over-Allotment Option [Member]            
Loss Contingencies [Line Items]            
Sale private placement warrants       11,500,000    
Underwriting discount         $ 0.20  
Sale of stock, consideration received on transaction       $ 115,000,000 $ 2,300,000  
Offering expenses         $ 100,000  
Public or Private Securities [Member]            
Loss Contingencies [Line Items]            
Percentage of aggregate sales price of securities sold 1.00%          
Underwriters [Member]            
Loss Contingencies [Line Items]            
Shares for future issuance         1,500,000  
Underwriters [Member] | Over-Allotment Option [Member]            
Loss Contingencies [Line Items]            
Sale private placement warrants       1,500,000    
Proceeds from sale of stock     $ 15,000,000